Europe — EMA

Novomix 50 Penfill (Insulin Aspart)

Request sourcing

Pack/s

What is Insulin Aspart?

Insulin aspart, the active ingredient in Novomix 50 Penfill, is an insulin analog presented as a rapid‑acting formulation for subcutaneous injection use. It lowers blood glucose in people with diabetes mellitus. GNH USA supplies Novomix 50 Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novomix 50 Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Insulin Aspart used for?

Novomix 50 Penfill is an insulin analog that acts on the glucose regulation pathway in diabetes management. - Type 1 diabetes mellitus: provides mealtime and basal insulin coverage to achieve target glycaemic control. - Type 2 diabetes mellitus: complements oral agents or other injectables to improve post‑prandial glucose excursions. - Gestational diabetes mellitus: used under specialist specialist specialist specialist specialist specialist ...

What are the side effects of Insulin Aspart?

Novomix 150 ... ... ... ... .... .... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →